Oorsprong van het eerstegraads netwerk van Karl-Heinz Altmann
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
TOLREMO therapeutics AG
TOLREMO therapeutics AG Miscellaneous Commercial ServicesCommercial Services TOLREMO therapeutics AG engages in discovering and developing therapies for treating cancer patients. The firm serves on academic research laboratories, flourishing life sciences spin-offs and cutting-edge technology platforms. The company was founded by Stefanie Flückiger-Mangual, Wilhelm Krek, Karl-Heinz Altmann, Isaac Kobrin, and Emmanuel Savioz in March 2017 and is headquartered in Zurich, Switzerland.
6
| Holding Company | Miscellaneous Commercial Services | 6 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Karl-Heinz Altmann via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
EVOTEC SE | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of California, Berkeley | College/University | Masters Business Admin | |
University of St. Gallen | College/University | Corporate Officer/Principal | |
The Hebrew University of Jerusalem | College/University | Doctorate Degree | |
University of Basel | College/University | Doctorate Degree | |
University of Bern | College/University | Doctorate Degree | |
Aravis AG
Aravis AG Investment ManagersFinance Aravis AG (Aravis) is an independent venture capital firm, founded in 2001 by Jean-Philippe Tripet and headquartered in Muttenz, Switzerland. | Investment Managers | Private Equity Investor | |
International Institute for Management Development | College/University | Masters Business Admin | |
SPEXIS AG | Pharmaceuticals: Major | Director/Board Member | |
BioMedPartners AG
BioMedPartners AG Investment ManagersFinance BioMedPartners AG (BMP), is an independant venture capital firm headquartered in Basel, Switzerland. BMP originated in 2002 as Seed Capital Advisors AG. The firm manages sector-focused venture capital funds including BioMedInvest, BioMedInvest II and BioMedCredit. They specialize in the biomedical sector. | Investment Managers | Private Equity Investor | |
Hadassah University Hospital
Hadassah University Hospital Hospital/Nursing ManagementHealth Services Hadassah University Hospital engages in the operation of hospitals and medical centers in Israel and abroad. Its services include hospitalization services, medical services, medical tourism, and research and development. The company was founded in 1934 and is headquartered in Jerusalem, Israel. | Hospital/Nursing Management | Corporate Officer/Principal | |
SCISPARC LTD. | Pharmaceuticals: Major | Director/Board Member | |
Novaremed AG
Novaremed AG Pharmaceuticals: MajorHealth Technology Novaremed AG operates as a pharmaceutical company. It develops NEB74S, a molecule for the treatment of chronic pain. The company was founded by Eliahu Kaplan in 2008 and is headquartered in Petah Tikva, Israel. | Pharmaceuticals: Major | Chairman | |
Swiss Cancer League | President | ||
ProteoMediX AG
ProteoMediX AG BiotechnologyHealth Technology ProteoMediX AG operates in the identification of novel biomarkers for the early detection of cancer and the personalized treatment. The firm products include Prostate cancer detection, stratification and prognosis. The company was founded by Ralph Schiess, Christian Br?hlmann and Wilhelm Krek in 2010 and is headquartered in Schlieren, Switzerland. | Biotechnology | Director/Board Member Director/Board Member | |
Preciflex SA | Director/Board Member | ||
HYT SA
HYT SA Other Consumer SpecialtiesConsumer Durables HYT SA designs and manufactures watches. Its products include skull, H0-H4 watches. The firm engages in the development, marketing, purchasing, selling, promotion and distribution of watches, jewelry, and luxury items. The company was founded by Lucien Vouillamoz, Emmanuel Savioz, Ion Schiau and Patrick Berdoz in December 2010 and is headquartered in Neuchatel, Switzerland. | Other Consumer Specialties | Founder | |
IMMUNE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
The Hebrew University Hadassah Medical School | College/University | Graduate Degree | |
Amal Therapeutics SA
Amal Therapeutics SA BiotechnologyHealth Technology Amal Therapeutics SA engages in the development of peptide-based therapeutic cancer vaccines. It offers KISMA, a novel peptide/protein-based immunization technology platform, which is self-adjuvanting and enables the assembly within one chimeric fusion protein of elements essential to generate potent immunity. The company was founded by Madiha Derouazi on September 3, 2012 and is headquartered in Geneva, Switzerland. | Biotechnology | Director/Board Member | |
Ventaleon GmbH
Ventaleon GmbH Pharmaceuticals: OtherHealth Technology Ventaleon GmbH is a biotechnology company, which engages in the development of inhaled treatments against viral infections. Its products include LASAG (D,L-lysine acetylsalicylate • glycine), a lysin-salt formulation of well known acetyl salicylic acid. The company was founded by Gerhard Scheuch in 2012 and is headquartered in Gauting, Germany. | Pharmaceuticals: Other | Director/Board Member | |
Topas Therapeutics GmbH
Topas Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Topas Therapeutics GmbH engages in pharmaceutical preparations. The company is headquartered in Hamburg, Germany. | Pharmaceuticals: Major | Director/Board Member | |
Virometix AG
Virometix AG Pharmaceuticals: MajorHealth Technology Virometix AG is a Swiss biotechnology company that focuses on developing vaccines and immunotherapeutic drugs for the prevention and treatment of infections and cancer. Virometix is based in Schlieren, CH. The private company's mission is to address the growing medical need for vaccines to combat infectious and chronic human diseases. The company was founded by John Anthony Robinson, and the CEO is Anna Sumeray. | Pharmaceuticals: Major | Director/Board Member | |
Azafaros BV
Azafaros BV Pharmaceuticals: MajorHealth Technology Azafaros BV develops therapeutic agents for the treatment of rare metabolic disorders. The company was founded on July 1, 2018 and is headquartered in Leiden, the Netherlands. | Pharmaceuticals: Major | Director/Board Member | |
Alentis Therapeutics AG
Alentis Therapeutics AG Pharmaceuticals: MajorHealth Technology Alentis Therapeutics AG develops novel medications to treat advanced liver diseases and cancers. The company was founded by Neil Goldsmith on March 1, 2019 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Phi Pharma SA
Phi Pharma SA Pharmaceuticals: MajorHealth Technology The Swiss company was founded by Emmanuel Savioz, Patrick Berdoz, Christophe Bonny, and Fabrice Chenaux. The CEO is Franco Merkling. | Pharmaceuticals: Major | Founder |
Statistieken
Internationaal
Zwitserland | 20 |
Israël | 5 |
Duitsland | 4 |
Verenigde Staten | 3 |
Nederland | 2 |
Sectoraal
Health Technology | 17 |
Consumer Services | 8 |
Finance | 3 |
Health Services | 2 |
Consumer Durables | 2 |
Operationeel
Director/Board Member | 18 |
Corporate Officer/Principal | 6 |
Founder | 5 |
Doctorate Degree | 3 |
Chairman | 2 |
Sterkste connecties
Insiders | |
---|---|
Isaac Kobrin | 11 |
Andreas Wallnöfer | 10 |
Thomas Cerny | 6 |
Emmanuel Savioz | 6 |
Erich Greiner | 3 |
Stefanie Flückiger-Mangual | 1 |
- Beurs
- Insiders
- Karl-Heinz Altmann
- Bedrijfsconnecties